« FDA Approvals - Kensey Nash Receives FDA 510(k) Clearance For TriActiv FX(R) Embolic | Main | FDA Approvals - St. Jude Medical Announces FDA Approval of Atlas II ICD »

Gardasil Cervical Cancer Vaccine (Gardisil)

GARDASIL (R), Merck's Investigational Cervical Cancer Vaccine, to Receive Priority Review from the U.S. Food and Drug (FinanzNachrichten)
Merck&Co., Inc. (Gardisil) announced today that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for GARDASIL(R) (quadrivalent human papillomavirus types 6, 11, 16, 18, recombinant vaccine) and that the investigational cervical cancer vaccine will be given priority review by the agency.

FDA News Search
Breaking FDA Recalls
Breaking FDA Approvals
Health Tip
  • It’s a little known fact that an espresso shot benefits your health in a variety of important ways.
Food & Drug Categories
FDA News Archive
Subscribe to this site's RSS feed
FDA Resources

FDA News Site Map
FDA Online Resources
FDA Related Resources
 

©2006 FDA-News.com. All rights reserved.